ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!ELOX Company Profile and Key Details
Eloxx Pharmaceuticals, Inc.
ELOX Stock Price Chart
Stock Price Today
Eloxx Pharmaceuticals, Inc. (ELOX) stock remained unchanged at $0.00 a share on NASDAQ. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.
Company Information
| Employees | 18 |
| Beta | -24.6 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) stock price is $0.00 in the last trading session. During the trading session, ELOX stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in ELOX stock occurred in the recent session was 0% while the dollar amount for the price change in ELOX stock was $0.00.
The NASDAQ listed ELOX is part of Biotechnology industry that operates in the broader Healthcare sector. Eloxx Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Ali Hariri M.D.
Chief Medical Officer
Mr. Matthew Goddeeris Ph.D.
Vice President of Research
Ms. Barbara Ryan
Investor Relations Officer
Mr. Sumit Aggarwal M.B.A.
Pres, Chief Executive Officer & Director
Dr. Vijay Modur MBBS, Ph.D.
Head of R&D
ELOX's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $1.39 is -99.99%.
Number of ELOX employees currently stands at 18.
Official Website of ELOX is: https://www.eloxxpharma.com
ELOX could be contacted at phone 781 577 5300 and can also be accessed through its website. ELOX operates from 480 Arsenal Way, Watertown, MA 02472, United States.
ELOX stock volume for the day was 1.26K shares. The average number of ELOX shares traded daily for last 3 months was 298.
The market value of ELOX currently stands at $314.00 with its latest stock price at $0.00 and 3.14M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com